Correlation of microalbumin and sialic acid with anthropometric variables in type 2 diabetic patients with and without nephropathy

Vascular Health and Risk Management

Volumn 4, Issue 1, 2008, Pages 243-247

  Nayak, B Shivananda ^a   Duncan, Heidi ^a   Lallo, Sunita ^a   Maraj, Kevin ^a   Matmungal, Vani ^a   Matthews, Felicia ^a   Prajapati, Bhupinder ^a   Samuel, Ria ^a   Sylvester, Pearse ^a  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

Author keywords

Diabetes; Microalbumin; Sialic acid

Indexed keywords

C REACTIVE PROTEIN; SIALIC ACID;

ADOLESCENT; ADULT; ALBUMIN BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DRUG ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROTEIN ANALYSIS; RISK FACTOR; SPECTROPHOTOMETRY; TRINIDAD AND TOBAGO; URINALYSIS; WAIST HIP RATIO;

ADOLESCENT; ADULT; ALBUMINURIA; ANALYSIS OF VARIANCE; ANTHROPOMETRY; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; N-ACETYLNEURAMINIC ACID; TRINIDAD AND TOBAGO;

EID: 41549098706     PISSN: 11766344     EISSN: None     Source Type: Journal    
DOI: 10.2147/vhrm.2008.04.01.243     Document Type: Article

References (23)

1. Abdella N, Akanji A, Mojiminiyi O, et al. 2000. Relationship of serum total sialic acid concentrations with diabetic complications and cardiovascular risk factors in Kuwaiti Type 2 diabetics. Diabetes Research and Clinical Practic, 50:65-72.
2. Browning LM, Jebb SA, Mishra GD, et al. 2004. Elevated sialic acid, but not CRP, predicts features of the metabolic syndrome independently of BMI in women. Int J Obes Relat, 28:1004-10.
3. Crook MA, Pickup JC, Lumb PJ, et al. 2001. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes. Diabetes Care, 24:316-22.
4. Crook MA, Goldsmith L, Ameerally P, et al. 2002. Serum sialic acid, a possible cardiovascular risk factor is not increased in Fijian Melanesians with impaired glucose tolerance or impaired fasting glucose. Ann Clin Biochem, 39:606-8.
5. Chen J, Gall M, Yokoyama H, et al. 1996. Raised serum silaic acid in NIDDM patients with and without diabetic nephropathy. Diabetes Care, 19:130-34.
6. Crook M, Earle, Morocutti A, et al. 1994. Serum sialic acid a risk factor for cardiovascular disease is increased in IDDM patients with microalbuminuria and clinical proteinuria. Diabetes Care, 17:305-10.
7. Crook M, Tutt P, Pickup JC. 1993. Elevated serum sialic acid concentrations in NIDDM and its relationship to blood pressure and retinopathy. Diabetes Care, 16:57-60.
8. Duncan BB, Schmidt M, Pankow JS, et al. 2003. Low grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. ADA, 52:1799-805.
9. English P, Williams G. 2001. Type 2 diabetes. London, Martin Dunitz Ltd. AnnNY Acad Sci, 1067:449-53.
10. Favier F, Jaussent I, Moullec N, et al. 2005. Prevalence of Type 2 diabetes and central adiposity in La Reunion Island. Diabetes Metab Res Rev, 22:1-12.
11. Haffner S, Greenberg A, Weston W, et al. 2002. Effect of Rosiglitazone treatment on non-traditional markers of cardiovascular disease in patients with type 2 diabetes. AHA, 106:679-84.
12. Lindberg G, Eklund GA, Gullberg B, et al. 1991. Serum sialic acid concentration and cardiovascular mortality. Br Med J, 302:143-46.
13. Lindberg G, Iso H, Rastum L, et al. 1997. serum sialic acid and its correlate in community samples from Akita, Japan and Minneapolis, USA. Int J Epidemiol, 26:58-63.
14. Melajarvi N, Gylling H, Miettinen T. 1996. Sialic acids and the metabolism of low density lipoprotein. J Lipid Res, 37:1625-31.
15. Nayak S, Bhaktha G. 2005. Relationship between sialic acid and metabolic variables in Indian type 2 diabetic patients. Lipid Health Dis, 4:15-19.
16. Pickup JC, 2004. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care, 27:813-23.
17. Raz I, Sharfrir ES. 2003. Diabetes: from research to diagnosis and treatment", Taylor and Francis Ltd.
18. Traving C, Schaver R. 1998. Structure and function and metabolism of diabetic control and complications. Cell Mol Life Sci, 54:1330-49.
19. Phillip MH. 2006. Prevention of progression in diabetic nephropathy Diabetes Spectrum, 19:18-24.
20. Winzler RT. 1955. Determination of serum glycoproteins. In: Glick, DT ed. Methods of Biochemical analysis. Vol II. Interscience Publishers, Inc, New York, pp. 298.
21. Welborn TA, Dhaliwal SS, Bennett SA. 2003. Waist - hip ratio is the dominant risk factor predicting cardiovascular death in Australia. Med J Aus, 179:580-85.
22. Yarema K. 2006. The sialic acid pathway in human cells. Baltimore: John Hopkins University.
23. Yokoyama H, Jensen J, Myrup B, et al. 1996. Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM. Diabetes Care, 19:435-40.